|
[1]
|
ESHRE, ASRM. International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome 2018. https://www.doc88.com/p-90499863252553.html
|
|
[2]
|
Li, R., Zhang, Q., Yang, D., et al. (2013) Prevalence of Polycystic Ovary Syndrome in Women in China: A Large Community-Based Study. Human Re-production, 28, 2562-2569. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Xu, N., Chua, A.K., Jiang, H., et al. (2014) Early Embryonic Androgen Exposure Induces Transgenerational Epigenetic and Metabolic Changes. Molecular Endocrinology, 28, 1329-1336. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Moran, C., Arriaga, M., Arechavale-ta-Velasco, F., et al. (2015) Adrenal Androgen Excess and Body Mass Index Inpolycystic Ovary Syndrome. The Jour-nal of Clinical Endocrinology & Metabolism, 100, 942-950. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Visser, J.A. (2021) The Importance of Metabolic Dysfunction in Poly-cystic Ovary Syndrome. Nature Reviews Endocrinology, 17, 77-78. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Hong, X., Qin, P., Yin, J., Shi, Y., Xuan, Y., Chen, Z., Zhou, X., Yu, H., Peng, D. and Wang, B. (2021) Clinical Manifestations of Polycystic Ovary Syndrome and Associations with the Vaginal Microbiome: A Cross-Sectional Based Exploratory Study. Frontiers in Endocrinology, 12, 662-725. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Tee, M.K. and Miller, W.L. (2013) Phosphorylation of Human Cytochrome P450c17 by p38α Selectively Increases 17,20 Lyase Activity and Androgen Biosynthesis. Journal of Bio-logical Chemistry, 288, 23903-23913. [Google Scholar] [CrossRef]
|
|
[8]
|
Garcia Barrado, M.J., Blanco, E.J., Carretero Hernandez, M., et al. (2014) Local Transformations of Androgens into Estradiol by Aromatase P450 Is Involved in the Regulation of Prolactin and the Proliferation of Pituitary Prolactin-Positive Cells. PLOS ONE, 9, el01403. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
沈晔, 金翠云, 李宏斌. 芳香化酶抑制剂治疗子宫腺肌病的临床效果及对患者性激素水平和P450表达的影响[J]. 中国妇幼保健, 2022, 37(18): 3351-3354.
|
|
[10]
|
张慧敏, 朱文倩, 马静, 等. 多囊卵巢综合征患者颗粒细胞中miR-1270及其靶基因CYP19A1的表达及临床意义[J]. 生殖医学杂志, 2021, 30(5): 649-657.
|
|
[11]
|
马艳鸽, 申爱荣, 李灿宇, 等. 子宫内膜异位症和子宫腺肌病在位、异位内膜间质细胞原代培养与形态学观察[J]. 中国妇幼保健, 2015, 12(2): 287-290.
|
|
[12]
|
王莱娜, 张萍. 子宫内膜异位症与关键核受体相关机制的研究进展[J]. 现代医学, 2022, 50(1): 130-135.
|
|
[13]
|
陆湘, 吴正沐, 王旻, 等. 子宫内膜异位症患者卵巢颗粒细胞SF-1基因启动子甲基化状态的研究[J]. 生殖与避孕, 2016, 12(7): 536-541.
|
|
[14]
|
苏晓华, 宋殿荣, 张英, 等. 子宫内膜异位症中子宫内膜间质细胞血管生成能力的研究[J]. 国际妇产科学杂志, 2015, 32(1): 49-53.
|
|
[15]
|
赵红, 丁晓萍. LRH-1在女性生殖和乳腺癌中的研究进展[J]. 北京师范大学学报, 2008, 44(3): 323-327.
|
|
[16]
|
Yin, M., Lv, M., Yao, G., Tian, H., et al. (2012) Transactivation of microRNA-383 by Steroidogenic Factor-1 Promotes Estradiol Release Form Mouse Ovarian Granulosa Cells by Targeting RBMS1. Molecular Endocri-nology, 26, 1129-1143. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
张璐, 李安迪, 杨楠, 等. 卵巢颗粒细胞中胰岛素和雄激素对芳香化酶和5α-还原酶1影响的研究[J]. 生殖医学杂志, 2017, 26(7): 711-717.
|
|
[18]
|
Yu, Y.-Y., Sun, C.-X., et al. (2013) Promoter Methylation of CYP19A1 Gene in Chinese Polycystic Ovary Syndrome Patients. Gynecologic and Obstetric Investigation, 76, 209-213. [Google Scholar] [CrossRef] [PubMed]
|